These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37523361)

  • 41. Update on the current status of onchocerciasis in Côte d'Ivoire following 40 years of intervention: Progress and challenges.
    Koudou BG; Kouakou MM; Ouattara AF; Yeo S; Brika P; Meite A; Aba E; King CL; Kouakou R; Weil GJ; Fischer PU
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006897. PubMed ID: 30352058
    [TBL] [Abstract][Full Text] [Related]  

  • 42. First evidence that parasite infecting apparent aparasitemic serological suspects in human African trypanosomiasis are Trypanosoma brucei gambiense and are similar to those found in patients.
    Kaboré J; Koffi M; Bucheton B; MacLeod A; Duffy C; Ilboudo H; Camara M; De Meeûs T; Belem AM; Jamonneau V
    Infect Genet Evol; 2011 Aug; 11(6):1250-5. PubMed ID: 21530681
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Population genetics of Trypanosoma brucei gambiense, the agent of sleeping sickness in Western Africa.
    Koffi M; De Meeûs T; Bucheton B; Solano P; Camara M; Kaba D; Cuny G; Ayala FJ; Jamonneau V
    Proc Natl Acad Sci U S A; 2009 Jan; 106(1):209-14. PubMed ID: 19106297
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The risk factors for relapse among patients with African trypanosomiasis in Daloa, Cote d'Ivoire.
    Cross P; Doua F; Jaffar S
    Trop Doct; 2006 Apr; 36(2):90-3. PubMed ID: 16611441
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preliminary evaluation of LATEX/T. b. gambiense and alternative versions of CATT/T. b. gambiense for the serodiagnosis of human african trypanosomiasis of a population at risk in Côte d'Ivoire: considerations for mass-screening.
    Jamonneau V; Truc P; Garcia A; Magnus E; Büscher P
    Acta Trop; 2000 Sep; 76(2):175-83. PubMed ID: 10936577
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Knowledge, attitudes and practices towards yaws in endemic areas of Ghana, Cameroon and Côte d'Ivoire.
    Beiras CG; Kouadio AT; Handley BL; Arhinful D; Tchatchouang S; Houndji ASS; Nartey ET; Sarpong DO; Menguena G; Ndzomo P; Basing LA; Hugues KA; Amanor IB; Bakheit M; Landmann E; Awondo P; Müller C; Crucitti T; Borst N; Becherer L; Lüert S; Frischmann S; Sylla A; Kouamé-Sina MS; Harding-Esch EM; Knauf S; Mitjà O; Eyangoh S; Addo KK; Kakou SN; Marks M
    PLoS Negl Trop Dis; 2024 Jun; 18(6):e0012224. PubMed ID: 38900827
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A miniature kit for the in vitro isolation of Trypanosoma brucei gambiense: a preliminary field assessment on sleeping sickness patients in Côte d'Ivoire.
    Truc P
    Trans R Soc Trop Med Hyg; 1996; 90(3):246-7. PubMed ID: 8758064
    [No Abstract]   [Full Text] [Related]  

  • 48. Potential population-level effects of HIV self-test distribution among key populations in Côte d'Ivoire, Mali, and Senegal: a mathematical modelling analysis.
    Silhol R; Maheu-Giroux M; Soni N; Simo Fotso A; Rouveau N; Vautier A; Doumenc-Aïdara C; Geoffroy O; N'Guessan KN; Sidibé Y; Kabemba OK; Gueye PA; Ndeye PD; Mukandavire C; Vickerman P; Keita A; Ndour CT; Larmarange J; Boily MC;
    Lancet HIV; 2024 Aug; 11(8):e531-e541. PubMed ID: 38991596
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modelling timelines to elimination of sleeping sickness in the Democratic Republic of Congo, accounting for possible cryptic human and animal transmission.
    Crump RE; Aliee M; Sutherland SA; Huang CI; Crowley EH; Spencer SEF; Keeling MJ; Shampa C; Mwamba Miaka E; Rock KS
    Parasit Vectors; 2024 Aug; 17(1):332. PubMed ID: 39123265
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human immunodeficiency virus infection and human African trypanosomiasis: a case-control study in Côte d'Ivoire.
    Meda HA; Doua F; Laveissière C; Miezan TW; Gaens E; Brattegaard K; de Muynck A; De Cock KM
    Trans R Soc Trop Med Hyg; 1995; 89(6):639-43. PubMed ID: 8594681
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Passive surveillance of human African trypanosomiasis in Côte d'Ivoire: Understanding prevalence, clinical symptoms and signs, and diagnostic test characteristics.
    Koné M; Kaba D; Kaboré J; Thomas LF; Falzon LC; Koffi M; Kouamé CM; Ahouty B; Compaoré CFA; N'Gouan EK; Solano P; Fèvre E; Büscher P; Lejon V; Jamonneau V
    PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009656. PubMed ID: 34460829
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk factors for rabies in Côte d'Ivoire.
    Tetchi MS; Coulibaly M; Kallo V; Traoré GS; Issaka T; Joseph BBV; Gerber F; Saric J; Lechenne M; Zinsstag J; Bonfoh B
    Acta Trop; 2020 Dec; 212():105711. PubMed ID: 32956636
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The natural progression of Gambiense sleeping sickness: what is the evidence?
    Checchi F; Filipe JA; Barrett MP; Chandramohan D
    PLoS Negl Trop Dis; 2008; 2(12):e303. PubMed ID: 19104656
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Population genetics of Glossina palpalis palpalis in sleeping sickness foci of Côte d'Ivoire before and after vector control.
    Berté D; De Meeûs T; Kaba D; Séré M; Djohan V; Courtin F; N'Djetchi Kassi M; Koffi M; Jamonneau V; Ta BTD; Solano P; N'Goran EK; Ravel S
    Infect Genet Evol; 2019 Nov; 75():103963. PubMed ID: 31301424
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Methodology to determine risk zones for sleeping sickness in Côte d'Ivoire by the spatial approach].
    Lointier M; Truc P; Drapeau L; Nanga S; Tarek M
    Med Trop (Mars); 2001; 61(4-5):390-6. PubMed ID: 11803832
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predicting the impact of COVID-19 interruptions on transmission of gambiense human African trypanosomiasis in two health zones of the Democratic Republic of Congo.
    Aliee M; Castaño S; Davis CN; Patel S; Miaka EM; Spencer SEF; Keeling MJ; Chitnis N; Rock KS
    Trans R Soc Trop Med Hyg; 2021 Mar; 115(3):245-252. PubMed ID: 33611586
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estimates of serious fungal infection burden in Côte d'Ivoire and country health profile.
    Koffi D; Bonouman IV; Toure AO; Kouadjo F; N'Gou MRE; Sylla K; Dosso M; Denning DW
    J Mycol Med; 2021 Mar; 31(1):101086. PubMed ID: 33259981
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Trypanosoma brucei gambiense-iELISA: A Promising New Test for the Post-Elimination Monitoring of Human African Trypanosomiasis.
    Geerts M; Van Reet N; Leyten S; Berghmans R; Rock KS; Coetzer THT; Eyssen LE; Büscher P
    Clin Infect Dis; 2021 Nov; 73(9):e2477-e2483. PubMed ID: 32856049
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Revisiting the immune trypanolysis test to optimise epidemiological surveillance and control of sleeping sickness in West Africa.
    Jamonneau V; Bucheton B; Kaboré J; Ilboudo H; Camara O; Courtin F; Solano P; Kaba D; Kambire R; Lingue K; Camara M; Baelmans R; Lejon V; Büscher P
    PLoS Negl Trop Dis; 2010 Dec; 4(12):e917. PubMed ID: 21200417
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ideational factors associated with net care behaviour: a multi-country analysis.
    Kumoji E'; Awantang GN; Toso M; Kamara D; Bleu T; Lahai W; Sillah-Kanu M; Dosso A; Achu D; Babalola S
    Malar J; 2022 Feb; 21(1):53. PubMed ID: 35177086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.